This inventor holds 2 USPTO granted patents. Top assignee: The Board of Regents of the University of Nebraska. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Innovations by Inventor Nicolas Moniaux
Introduction
Nicolas Moniaux is a prominent inventor based in Omaha, NE (US). He has made significant contributions to the field of cancer research, particularly in the area of pancreatic cancer. With a total of 2 patents, his work focuses on innovative methods to inhibit cancer metastasis.
Latest Patents
Moniaux's latest patents include groundbreaking research on compositions and methods for inhibiting pancreatic cancer metastasis. This patent outlines methods for the inhibition of metastasis of cancer cells expressing MUC4, specifically targeting metastatic pancreatic cancer cells. Another notable patent involves MUC17 encoding nucleic acid sequences, polypeptides, antibodies, and methods of use thereof. This patent discloses human MUC17-encoding nucleotide sequences, proteins, antibodies, and their applications in cancer treatment.
Career Highlights
Nicolas Moniaux is affiliated with the University of Nebraska, where he conducts his research and development. His work has garnered attention for its potential impact on cancer therapies and patient outcomes.
Collaborations
Moniaux collaborates with esteemed colleagues, including Surinder K Batra and Ajay P Singh, who contribute to his research endeavors and enhance the scope of his work.
Conclusion
Nicolas Moniaux's innovative contributions to cancer research, particularly in pancreatic cancer, highlight his role as a significant inventor in the field. His patents reflect a commitment to advancing medical science and improving treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile